Alpha-amylase mutants
AssigneeNovozymes A/S
InventorsAllan Svendsen, Torben Vedel Borchert, Henrik Bisgard-Frantzen
Life of this patent
Estimating the term…
Abstract
The invention relates to a variant of a parent Termamyl-like a-amylase, which variant has a-amylase activity and exhibits an alteration in at least one of the following properties relative to said parent a-amylase: substrate specificity, substrate binding, substrate cleavage pattern, thermal stability, pH/activity profile, pH/stability profile, stability towards oxidation, Ca2+ dependency and specific activity.
Claims23
A variant of a parent Termamyl-like α-amylase, which variant has α-amylase activity and exhibits an alteration in at least one of the following properties relative to said parent α-amylase:
- substrate specificity, substrate binding, substrate cleavage pattern, thermal stability, pH/activity profile, pH/stability profile, stability towards oxidation, Ca2+ dependency and specific activity;
- said variant comprising one or more mutations corresponding to one or more of the following mutations in the amino acid sequence shown in SEQ ID No. 2:
- the mutations:
- A181E,D,Q,N,V;
- I201 (bulkier amino acid), including I201W,F,L;
- Y203Q;
- Q9K,L,E;
- F11R,K,E;
- E12Q;
- D100N,L;
- V101H,R,K,D,E,F;
- V102A,T;
- I103H,K;
- N104R,K,D;
- H105R,K,D,E,W,F;
- L196R,K,D,E,F,Y;
- I212R,K,D,E;
- L230H,K,I;
- A232G,H,F,S,V;
- V233D;
- K234L,E;
- I236R,K,N,H,D,E;
- L241R,K,D,E,F;
- A260S;
- W263H;
- Q264R,D,K,E;
- N265K,R,D;
- A269R,K,D,E;
- L270R,K,H,D,E;
- V283H,D;
- F284H;
- D285N,L;
- V286R,K,H,D,E;
- Y290R,E,K;
- V312R,K,D,E;
- F323H;
- D325N;
- N326K,H,D,L;
- H327Q,N,E,D,F;
- Q330L,E;
- G332D;
- Q333R,K,H,E,L;
- S334A,V,T,L,I,D;
- L335G,A,S,T,N;
- E336R+R375E;
- T337D,K;
- T338D,E;
- T339D;
- Q360K,R,E;
- D365N;
- or G371D,R;
- substitutions at positions H68, H91, H247, R305, K306, H382, K389, H405, H406, H450 or R483;
- the mutations:
- H140Y;
- H142Y;
- H159Y;
- H140D+H142R;
- H140K+H142D;
- or H142Y+H156Y;
- deletion of three amino acids within the partial sequence from T369 to I377, including the deletions:
- K370*+G371*+D372* or D372*+S373*+Q374*;
- replacement of the partial amino acid sequence from T369 to I377 with one of the following sequences (sequence number increasing from left to right):
- I-P-T-H-S-V;
- I-P-T-H-G-V;
- I-P-Q-Y-N-I;
- substitutions at positions R169 or R173, including R169I,L,F,T or R173I,L,F,T;
- the mutations H156D;
- I201F;
- I212F;
- A209L,T;
- or V208I;
- substitutions at positions N172, A181, N188, N190, H205, D207, A209, A210, E211, Q264 or N265, including N172R,H,K;
- A181T;
- N188P;
- N190L,F;
- H205C;
- D207Y;
- A209L,T,V;
- A210S;
- E211Q;
- Q264A,E,L,K,S,T;
- N265A,S,T,Y;
- or Q264S+N265Y;
- the mutations:
- H156Y+A181T+A209V;
- H156Y+A181T+N190F+A209V+Q264S;
- A1*+N2*+L3V+M15T+R23K+S29A+A30E+Y31H+A33S+E34D+H35I+H156Y+A181T+A209V;
- A1*+N2*+L3V+M15T+R23K+S29A+A30E+Y31H+A33S+E34D+H35I+H156Y+A181T+N190F+A209V;
- or
- A1*+N2*+L3V+M15T+R23K+S29A+A30E+Y31H+A33S+E34D+H35I+H156Y+A181T+N190F+A209V+Q264S.
A composition comprising:
- (i) a mixture of the α-amylase from B. licheniformis having the sequence shown in SEQ ID No. 2 with one or more variants according to the invention derived from (as the parent Termamyl-like α-amylase) the B. stearothermophilus α-amylase having the sequence shown in SEQ ID No. 6;
- or
- (ii) a mixture of the α-amylase from B. stearothermophilus having the sequence shown in SEQ ID No. 6 with one or more variants according to the invention derived from one or more other parent Termamyl-like α-amylases;
- or
- (iii) a mixture of one or more variants according to the invention derived from (as the parent Termamyl-like α-amylase) the B. stearothermophilus α-amylase having the sequence shown in SEQ ID No. 6 with one or more variants according to the invention derived from one or more other parent Termamyl-like α-amylases.
A method for generating a variant of a parent Termamyl-like α-amylase, which variant exhibits increased stability at low pH and at low calcium concentration relative to the parent, the method comprising:
- (a) subjecting a DNA sequence encoding the parent Termamyl-like α-amylase to random mutagenesis,
- (b) expressing the mutated DNA sequence obtained in step (a) in a host cell, and
- (c) screening for host cells expressing a mutated α-amylase which has increased stability at low pH and low calcium concentration relative to the parent α-amylase.
Dependencies are inferred from the claim text.